PE20090621A1 - Pirrolidina-aril-eteres como antagonistas de receptores de nk3 - Google Patents

Pirrolidina-aril-eteres como antagonistas de receptores de nk3

Info

Publication number
PE20090621A1
PE20090621A1 PE2008001420A PE2008001420A PE20090621A1 PE 20090621 A1 PE20090621 A1 PE 20090621A1 PE 2008001420 A PE2008001420 A PE 2008001420A PE 2008001420 A PE2008001420 A PE 2008001420A PE 20090621 A1 PE20090621 A1 PE 20090621A1
Authority
PE
Peru
Prior art keywords
aryl
piperazin
pyrrolidin
phenyl
ethyl
Prior art date
Application number
PE2008001420A
Other languages
English (en)
Inventor
Philippe Jablonski
Kenichi Kawasaki
Henner Knust
Anja Limberg
Matthias Nettekoven
Hasane Ratni
Claus Riemer
Xihan Wu
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE20090621A1 publication Critical patent/PE20090621A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Abstract

SE REFIERE A COMPUESTOS DERIVADOS DE PIRROLIDINA-ARIL-ETERES DE FORMULA (I) DONDE Ar ES ARILO O HETEROARILO DE 5 O 6 MIEMBROS; (i) ES UN RESTO MONO O BIHETEROCICLICO DE 6 A 9 ESLABONES, EN DONDE X ES C, SO2, N U O; R1 ES H, OH, CN, S(O)2-ALQUILO INFERIOR, ENTRE OTROS; R2 ES H, HALOGENO, ALQUILO INFERIOR, CN, ENTRE OTROS; R3 ES H O HALOGENO; R4 ES H O ALQUILO INFERIOR; n, o Y p SON CADA UNO 1 O 2; s ES DE 0 A 4. SON COMPUESTOS PREFERIDOS: {(3RS,4SR)-3-(3,4-DICLORO-FENIL)-4-[(RS)-1-(4-TRIFLUORMETIL-FENOXI)-ETIL]-PIRROLIDIN-1-IL}-(4-METANOSULFONIL-PIPERAZIN-1-IL)-METANONA, 2-(4-ACETIL-PIPERAZIN-1-IL)-1-{(3RS,4SR)-3-(3,4-DICLORO-FENIL)-4-[(RS)-1-(4-TRIFLUORMETIL-FENOXI)-ETIL]-PIRROLIDIN-1-IL}-ETANONA, [(3RS,4SR)-3-(3,4-DICLORO-FENIL)-4-((RS)-1-p-TOLILOXI-ETIL)-PIRROLIDIN-1-IL]-(4-METANOSULFONIL-PIPERAZIN-1-IL)-METANONA, ENTRE OTROS. SE REFIERE TAMBIEN A UN PROCEDIMIENTO DE PREPARACION Y A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON ANTAGONISTAS DE LOS RECEPTORES DE NEUROQUININAS 3 (NK-3) SIENDO UTILES EN EL TRATAMIENTO DE LA ANSIEDAD, DEPRESION, ESQUIZOFRENIA
PE2008001420A 2007-08-22 2008-08-21 Pirrolidina-aril-eteres como antagonistas de receptores de nk3 PE20090621A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07114790 2007-08-22

Publications (1)

Publication Number Publication Date
PE20090621A1 true PE20090621A1 (es) 2009-05-16

Family

ID=39870345

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001420A PE20090621A1 (es) 2007-08-22 2008-08-21 Pirrolidina-aril-eteres como antagonistas de receptores de nk3

Country Status (18)

Country Link
US (1) US7812021B2 (es)
EP (1) EP2190815B1 (es)
JP (1) JP2010536818A (es)
KR (1) KR101194467B1 (es)
CN (1) CN101861302A (es)
AR (1) AR067991A1 (es)
AT (1) ATE519738T1 (es)
AU (1) AU2008290634B2 (es)
BR (1) BRPI0815674A2 (es)
CA (1) CA2697325A1 (es)
CL (1) CL2008002450A1 (es)
ES (1) ES2369955T3 (es)
MX (1) MX2010001774A (es)
PE (1) PE20090621A1 (es)
RU (1) RU2010108687A (es)
TW (1) TW200916462A (es)
WO (1) WO2009024502A1 (es)
ZA (1) ZA201001125B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8063075B2 (en) * 2008-06-10 2011-11-22 Hoffmann-La Roche Inc. Pyrrolidine ether derivatives as NK3 receptor antagonists
AU2009301212A1 (en) * 2008-10-09 2010-04-15 F. Hoffmann-La Roche Ag Pyrrolidine n-benzyl derivatives
EP2391615B1 (en) 2009-01-30 2013-01-16 F. Hoffmann-La Roche AG Piperidine derivatives as nk3 receptor antagonists
US8318759B2 (en) * 2009-02-18 2012-11-27 Hoffmann-La Roche Inc. Pyrrolidine derivatives as NK3 receptor antagonists
SA110310332B1 (ar) 2009-05-01 2013-12-10 Astrazeneca Ab مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل )
US8394834B2 (en) * 2009-08-25 2013-03-12 Hoffman-La Roche Inc. Pyrrolidines as NK3 receptor antagonists
US20110144081A1 (en) 2009-12-15 2011-06-16 Henner Knust Pyrrolidine derivatives
US20110152233A1 (en) * 2009-12-18 2011-06-23 Henner Knust Pyrrolidine compounds
SG186275A1 (en) 2010-07-06 2013-01-30 Astrazeneca Ab Therapeutic agents 976
US8507535B2 (en) * 2010-07-07 2013-08-13 Hoffmann-La Roche Inc. Methyl-pyrrolidine ether derivatives
US8618303B2 (en) * 2011-01-07 2013-12-31 Hoffmann-La Roche Inc. Pyrrolidine derivatives
UY34194A (es) 2011-07-15 2013-02-28 Astrazeneca Ab ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad?
WO2018152286A1 (en) 2017-02-17 2018-08-23 Trevena, Inc. 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same
BR112019016827A2 (pt) 2017-02-17 2020-04-07 Trevena Inc compostos moduladores de receptor delta-opioide contendo aza-heterocíclico com 5 membros, métodos de uso e produção dos mesmos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (es) 1977-06-03 1981-03-07 Pfizer
GB9321557D0 (en) * 1992-11-03 1993-12-08 Zeneca Ltd Carboxamide derivatives
CA2162786A1 (en) * 1994-11-22 1996-05-23 Philip Arthur Hipskind Heterocyclic tachykinin receptor antagonists
BR9714057A (pt) 1996-12-19 2000-05-09 Hoechst Marion Roussel Inc Derivados heterocìclicos de pirrolidina amida substituìda.
US7468437B2 (en) * 2003-09-30 2008-12-23 Merck & Co., Inc. Phenyl pyrrolidine ether tachykinin receptor antagonists
US7138423B2 (en) * 2004-07-20 2006-11-21 Bristol-Myers Squibb Company Arylpyrrolidine derivatives as NK-1 /SSRI antagonists
CN101061096A (zh) * 2004-11-22 2007-10-24 默克公司 环烷基酮基哌啶速激肽受体拮抗剂
EP1817302A4 (en) * 2004-11-22 2009-07-01 Merck & Co Inc PIPERIDINYLPIPERIDIN-tachykinin receptor Antagonist
MX2010001080A (es) * 2007-08-07 2010-03-01 Hoffmann La Roche Pirrolidin-aril-eteres como antagonistas de receptor de nk3.

Also Published As

Publication number Publication date
CL2008002450A1 (es) 2009-07-31
BRPI0815674A2 (pt) 2015-02-18
KR20100043105A (ko) 2010-04-27
WO2009024502A1 (en) 2009-02-26
AR067991A1 (es) 2009-10-28
US7812021B2 (en) 2010-10-12
MX2010001774A (es) 2010-03-10
CA2697325A1 (en) 2009-02-26
TW200916462A (en) 2009-04-16
ES2369955T3 (es) 2011-12-09
EP2190815B1 (en) 2011-08-10
ATE519738T1 (de) 2011-08-15
AU2008290634B2 (en) 2012-12-06
US20090054644A1 (en) 2009-02-26
CN101861302A (zh) 2010-10-13
RU2010108687A (ru) 2011-09-27
ZA201001125B (en) 2010-10-27
AU2008290634A1 (en) 2009-02-26
JP2010536818A (ja) 2010-12-02
KR101194467B1 (ko) 2012-10-24
EP2190815A1 (en) 2010-06-02

Similar Documents

Publication Publication Date Title
PE20090621A1 (es) Pirrolidina-aril-eteres como antagonistas de receptores de nk3
PE20091173A1 (es) Derivados de heteroarilo como antagonistas de receptor de orexina
PE20081755A1 (es) Nuevas 2-aminooxazolinas como ligandos taar1
PE20090898A1 (es) Pirrolidina-aril-eteres como antagonistas de receptor de nk3
PE20090237A1 (es) Derivados de sulfonamidas como inhibidores de los canales de sodio
PE20090816A1 (es) Derivados de pirrolopirimidinona como agentes ligandos de los receptores p2x3
PE20120635A1 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasas
PE20081665A1 (es) Antagonistas del receptor de dopamina 2 de rapida disociacion
PE20121050A1 (es) Compuestos de n-(1-(4-(1h-pirazol-5-il)ftalazin-1-il)piperidin-4-il)-benzamida sustituidos como antagonistas de la trayectoria hedgehog
PE20080858A1 (es) Compuestos de n-aril pirazol y composiciones que los contienen
EA200700117A1 (ru) N-замещенные пиперидины и их применение в качестве фармацевтических препаратов
PE20081238A1 (es) Piperidinas sustituidas como antagonistas de hdm2
PE20060736A1 (es) DERIVADOS DE PIRROL COMO ANTAGONISTAS DE CRTh2
ATE483706T1 (de) Weitere heteropolycyclische verbindungen und deren verwendung als antagonisten des metabotropen glutamatrezeptors
PE20090622A1 (es) Nuevos derivados de bencimidazol sustituido
AR049696A1 (es) Derivados de indol
PE20081845A1 (es) Nuevos derivados de aminopirimidina como inhibidores de plk1
PE20060011A1 (es) COMPUESTOS AMIDAS DE ACIDOS CARBOXILICOS COMO INHIBIDORES DEL FACTOR Xa
PE20080889A1 (es) Aminometil-4-imidazoles
PE20090709A1 (es) Compuestos heterociclico de 5 miembros
PE20110405A1 (es) Derivados de piridino-piridinonas como inhibidores de la actividad de la tirosina quinasa de pdgf-r y/o flt-3 y su preparacion
PE20110410A1 (es) Derivado de 7-piperidinoalquil-3,4-dihidroquinolona
PE20070016A1 (es) Compuestos heterociclicos n-enlazados como antagonistas del receptor p2y1
PE20071161A1 (es) Derivados de urea sustituidos como moduladores del sarcomero cardiaco
PE20091090A1 (es) Derivados de piperidina como agonistas de receptores muscarinicos

Legal Events

Date Code Title Description
FC Refusal